154 related articles for article (PubMed ID: 30911303)
1. Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction.
Murakami N; Shima S; Kashihara T; Tselis N; Kato T; Takagawa Y; Masui K; Yoshida K; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
J Contemp Brachytherapy; 2019 Feb; 11(1):1-7. PubMed ID: 30911303
[TBL] [Abstract][Full Text] [Related]
2. Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study.
Takatsu J; Murakami N; Muramoto Y; Karino T; Oshima M; Kosugi Y; Kawamoto T; Terao Y; Shikama N
Brachytherapy; 2024; 23(2):115-122. PubMed ID: 38040605
[TBL] [Abstract][Full Text] [Related]
3. Effect of Hyaluronate Acid Injection on Dose-Volume Parameters in Brachytherapy for Cervical Cancer.
Kobayashi R; Murakami N; Chiba T; Okuma K; Inaba K; Takahashi K; Kaneda T; Kashihara T; Takahashi A; Shimizu Y; Nakayama Y; Kato T; Ito Y; Igaki H
Adv Radiat Oncol; 2022; 7(3):100918. PubMed ID: 35647394
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
5. Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the 'adjusted dose score'.
Miyata Y; Ogo E; Murotani K; Tsuda N; Suzuki G; Tsuji C; Akeda R; Muraki K; Hattori C; Abe T
J Radiat Res; 2024 May; 65(3):393-401. PubMed ID: 38739893
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies.
Murakami N; Nakamura S; Kashihara T; Kato T; Shibata Y; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Galalae R; Itami J
Brachytherapy; 2020; 19(2):154-161. PubMed ID: 31879238
[TBL] [Abstract][Full Text] [Related]
7. Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.
Basu S; Manir KS; Basu A; Ghosh K
J Contemp Brachytherapy; 2016 Oct; 8(5):399-403. PubMed ID: 27895681
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience.
Kashihara T; Murakami N; Tselis N; Kobayashi K; Tsuchida K; Shima S; Masui K; Yoshida K; Takahashi K; Inaba K; Umezawa R; Igaki H; Ito Y; Kato T; Uno T; Itami J
J Radiat Res; 2019 Jul; 60(4):501-508. PubMed ID: 31034570
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
10. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
[TBL] [Abstract][Full Text] [Related]
11. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
12. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
13. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
14. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session.
Oh D; Huh SJ; Park W; Ju SG; Nam H; Lee JE
Medicine (Baltimore); 2016 Jun; 95(25):e3895. PubMed ID: 27336876
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
18. Effect of bladder volume on radiation doses to organs at risk and tumor in cervical cancer during image-guided adaptive brachytherapy and treatment outcome analysis.
Xu Z; Yang L; Ma L; Liu Q; Chang AT; Zhou Y; Zhou C; Kong FM; Chen L
Mol Clin Oncol; 2021 Dec; 15(6):258. PubMed ID: 34765192
[TBL] [Abstract][Full Text] [Related]
19. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
[TBL] [Abstract][Full Text] [Related]
20. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
Wali L; Helal A; Darwesh R; Attar M
J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
